...And Grappling With Its Risks

Averting Catastrophe: Strategies for Regulating Risky Technologies. Joseph G. Morone and Edward J. Woodhouse. University of California Press, Berkeley, 1986. 215 pp. $17.95 The year 1986, which began as we were still reeling from Bhopal, brought Chernobyl's reminder of the international potential of major technological accidents, Challenger's reminder of the fallibility of even the most sophisticated engineering management systems (and human hubris), Lake Nyos' reminder that nature itself is not

Written byWilliam Lowrance
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Thus we hardly could be more sensitized to the question Morone and Woodhouse raise in their book: "Why, despite close calls, have risky civilian technologies produced no catastrophes in the United States? Have we simply been lucky—or is our good fortune at least partly the result of deliberate efforts to protect against these hazards?"

The authors are social process-oriented. They confess: "At the outset of this research, we approached this subject with the commonly held assumption that the United States had botched the job of regulating risky technologies. Yet when we actually delved into how regulators have coped with the various risks, we discovered a surprisingly intelligent process."

Five case studies on U.S. civilian technologies form the core of the analysis in Averting Catastrophe: toxic chemicals, nuclear reactors, recombinant DNA research, threats to the ozone layer and the atmospheric greenhouse problem. As the authors recognize, any book based on only ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control